Survivors work to keep Epstein files in spotlight ahead of midterm elections in Ohio
05:42
Warrants used to search former Prince Andrew's homes were unlawful, court says
02:33
Pentagon says it will livestream firing squad execution of Fort Hood shooter
02:49
USS Lincoln returns home after record deployment at sea
01:46
Coco Gauff speaks out about ‘insane’ wave of racist abuse online after replayed point
02:32
‘Everybody is here for her’: Cornell students stage sit-in for Jane Doe
04:30
Remembering the impact on the ground three years after the October 7th attacks on Israel
03:43
NTSB releases preliminary report on L.A. news chopper crash
02:16
Christa Pike now conscious and speaking following failed execution
03:24
NATO expands defense training in member states as Russia drone threats escalate in Europe
05:00
OpenAI CEO Sam Altman says people need to 'accept some bad things' for the benefits of AI
03:31
Former 'American Idol' contestant sentenced to life in prison without parole for wife's murder
03:07
Cornell students protest handling of alleged 2024 sexual assault
04:42
Maryland's new law targets surveillance pricing as algorithms reshape what consumers pay
04:01
With more deaths than births in Ukraine, having babies becomes an act of national pride
10:36
Tony Romo parts ways with CBS Sports after drunk driving arrest
01:54
Federal judge orders Trump administration to stop border wall construction at Big Bend National Park
01:44
Inside Walmart's push to win fashion shoppers with $25-and-under looks, new bohemian brand
03:30
Trump-proposed arch near Arlington Cemetery sparks protests
04:40
NBC News NOW
FDA grants first ever approval for Alzheimer’s drug meant to slow disease
Catch up with NBC News Clone on today's hot topic: Alzheimer S Drug Fully Approved By Fda Meant To Slow Disease 187049029886 - Breaking News | NBC News Clone. Our editorial team reformatted this story for clarity and speed.
02:57
Copied
The Food and Drug Administration fully approved the Alzheimer’s drug Leqembi, meant to slow development of the disease. Treatment costs $26,500 per year and is only approved for people in the early stages of Alzheimer's. July 6, 2023
